This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
December 10, 2015
BONESUPPORT™ ANNOUNCES RESULTS OF CERAMENT™|BONE VOID FILLER PROSPECTIVE PILOT STUDY DEMONSTRATING COMPLETE BONE REMODELING IN BENIGN BONE TUMORS
December 10, 2015
First patient enters Phase III TANGO clinical trial to evaluate efficacy to regress atherosclerosis and safety of CER-001 in patients with Familial Primary HypoAlphalipoproteinemia (FPHA)
December 10, 2015
HealthCap Investor Seminar
December 09, 2015
New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits of Pulmonx’s Medical Device for Emphysema
December 08, 2015
RSPR Pharma initiates Phase II clinical trial of oral mast cell inhibitor CRD007 in uncontrolled asthma
December 07, 2015
Strongbridge Biopharma Announces Issuance of U.S. Patent for Investigational COR-003 (levoketoconazole) in Treatment of Endogenous Cushing’s Syndrome
December 07, 2015
NORDIC NANOVECTOR PRESENTS PRECLINICAL RESEARCH WITH BETALUTIN® SHOWING POTENTIAL FOR COMBINATION WITH RITUXIMAB IN NON-HODGKIN LYMPHOMA
December 03, 2015
Nexstim Plc Announces Completion of Enrolment of Phase III Clinical Trial in Stroke Therapy
November 30, 2015
HealthCap opens office in Oslo and Ludvik Sandnes appointed as Special Advisor
November 30, 2015
HealthCap opens office in Oslo and Ludvik Sandnes appointed as Special Advisor